Cargando…

In Vitro and In Silico Analysis of Epithelial-Mesenchymal Transition and Cancer Stemness as Prognostic Markers of Clear Cell Renal Cell Carcinoma

SIMPLE SUMMARY: Clear cell renal cell carcinoma (ccRCC) is a highly aggressive cancer responsible for about 85% of kidney cancers. The majority of the incidentally detected renal masses are small and confined to the kidney; however, a significant number of patients initially present with progressive...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sharma, Revati, Balta, Showan, Raza, Ali, Escalona, Ruth M., Kannourakis, George, Prithviraj, Prashanth, Ahmed, Nuzhat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177434/ https://www.ncbi.nlm.nih.gov/pubmed/37174052 http://dx.doi.org/10.3390/cancers15092586

Ejemplares similares

Precision Medicine: An Optimal Approach to Patient Care in Renal Cell Carcinoma
por: Sharma, Revati, et al.
Publicado: (2022)

Determinants of resistance to VEGF-TKI and immune checkpoint inhibitors in metastatic renal cell carcinoma
por: Sharma, Revati, et al.
Publicado: (2021)

Expression of TIMPs and MMPs in Ovarian Tumors, Ascites, Ascites-Derived Cells, and Cancer Cell Lines: Characteristic Modulatory Response Before and After Chemotherapy Treatment
por: Escalona, Ruth M., et al.
Publicado: (2022)

Prognostic value of epithelial-mesenchymal transition markers in clear cell renal cell carcinoma
por: Xu, Hua, et al.
Publicado: (2020)

Platinum-resistance in epithelial ovarian cancer: an interplay of epithelial–mesenchymal transition interlinked with reprogrammed metabolism
por: Leung, Dilys, et al.
Publicado: (2022)

Aberrant pregnancy-associated plasma protein-A expression in breast cancers prognosticates clinical outcomes
por: Prithviraj, Prashanth, et al.
Publicado: (2020)

Prognostic Role of Immune Checkpoint Regulators in Cholangiocarcinoma: A Pilot Study
por: Cao, Lu, et al.
Publicado: (2021)

TIMP-2 regulates proliferation, invasion and STAT3-mediated cancer stem cell-dependent chemoresistance in ovarian cancer cells
por: Escalona, Ruth M., et al.
Publicado: (2020)

Clear Cell Renal Cell Carcinoma is linked to Epithelial‐to‐Mesenchymal Transition and to Fibrosis
por: Landolt, Lea, et al.
Publicado: (2017)

Unique proteome signature of post-chemotherapy ovarian cancer ascites-derived tumor cells
por: Ahmed, Nuzhat, et al.
Publicado: (2016)

The Many Facets of Metzincins and Their Endogenous Inhibitors: Perspectives on Ovarian Cancer Progression
por: Escalona, Ruth M., et al.
Publicado: (2018)

MicroRNA-21 stimulates epithelial-to-mesenchymal transition and tumorigenesis in clear cell renal cells
por: CAO, JIAN, et al.
Publicado: (2016)

Cancer Stem Cell Marker Endoglin (CD105) Induces Epithelial Mesenchymal Transition (EMT) but Not Metastasis in Clear Cell Renal Cell Carcinoma
por: Hu, Junhui, et al.
Publicado: (2019)

Thrombospondin 1 promotes an aggressive phenotype through epithelial-to-mesenchymal transition in human melanoma
por: Jayachandran, Aparna, et al.
Publicado: (2014)

Classification of Circulating Tumor Cells by Epithelial-Mesenchymal Transition Markers
por: Wu, Shiyang, et al.
Publicado: (2015)

Crosstalk between Immune Checkpoint Modulators, Metabolic Reprogramming and Cellular Plasticity in Triple-Negative Breast Cancer
por: Poddar, Arpita, et al.
Publicado: (2022)

Construction of an Epithelial-Mesenchymal Transition-Related Model for Clear Cell Renal Cell Carcinoma Prognosis Prediction
por: Zhu, Shimiao, et al.
Publicado: (2022)

In Silico Analysis of Ion Channels and Their Correlation with Epithelial to Mesenchymal Transition in Breast Cancer
por: Parthasarathi, K. T. Shreya, et al.
Publicado: (2022)

Knockdown of stem cell regulator Oct4A in ovarian cancer reveals cellular reprogramming associated with key regulators of cytoskeleton-extracellular matrix remodelling
por: Samardzija, Chantel, et al.
Publicado: (2017)

Ovarian Cancer, Cancer Stem Cells and Current Treatment Strategies: A Potential Role of Magmas in the Current Treatment Methods
por: Ahmed, Nuzhat, et al.
Publicado: (2020)

Overexpression of PPT2 Represses the Clear Cell Renal Cell Carcinoma Progression by Reducing Epithelial-to-mesenchymal Transition
por: Yuan, ChangFei, et al.
Publicado: (2020)

Knock down of TIMP-2 by siRNA and CRISPR/Cas9 mediates diverse cellular reprogramming of metastasis and chemosensitivity in ovarian cancer
por: Escalona, Ruth M., et al.
Publicado: (2022)

The Use of Automated Quantitative Analysis to Evaluate Epithelial-to-Mesenchymal Transition Associated Proteins in Clear Cell Renal Cell Carcinoma
por: O'Mahony, Fiach C., et al.
Publicado: (2012)

FGF18 Inhibits Clear Cell Renal Cell Carcinoma Proliferation and Invasion via Regulating Epithelial-Mesenchymal Transition
por: Yang, Chen, et al.
Publicado: (2020)

Identification of Epithelial–Mesenchymal Transition-Related lncRNA With Prognosis and Molecular Subtypes in Clear Cell Renal Cell Carcinoma
por: Zhong, Weimin, et al.
Publicado: (2020)

Deep Learning–Based Classification of Epithelial–Mesenchymal Transition for Predicting Response to Therapy in Clear Cell Renal Cell Carcinoma
por: Chen, Qiwei, et al.
Publicado: (2022)

Heterogeneity of expression of epithelial–mesenchymal transition markers in melanocytes and melanoma cell lines
por: Kim, Ji Eun, et al.
Publicado: (2013)

Epithelial-mesenchymal Transition and Cell Invasion
por: Son, Hwajin, et al.
Publicado: (2010)

Extracellular Acidosis Modulates the Expression of Epithelial-Mesenchymal Transition (EMT) Markers and Adhesion of Epithelial and Tumor Cells
por: Riemann, Anne, et al.
Publicado: (2019)

Epithelial-to-mesenchymal transition markers are differentially expressed in epithelial cancer cell lines after everolimus treatment
por: Gonçalves, Bryan Ôrtero Perez, et al.
Publicado: (2020)

SNX5 suppresses clear cell renal cell carcinoma progression by inducing CD44 internalization and epithelial-to-mesenchymal transition
por: Zhou, Qingqing, et al.
Publicado: (2021)

Antitumor activity of RUNX3: Upregulation of E-cadherin and downregulation of the epithelial–mesenchymal transition in clear-cell renal cell carcinoma
por: Yang, Ruo-Nan, et al.
Publicado: (2022)

Expression of epithelial-mesenchymal transition markers at the invasive front of oral squamous cell carcinoma
por: COSTA, Liana Cristina Melo Carneiro, et al.
Publicado: (2015)

Conversion of epithelial-to-mesenchymal transition to mesenchymal-to-epithelial transition is mediated by oxygen concentration in pancreatic cancer cells
por: Chen, Shuo, et al.
Publicado: (2018)

Conversion of epithelial-to-mesenchymal transition to mesenchymal-to-epithelial transition is mediated by oxygen concentration in pancreatic cancer cells
por: Chen, Shuo, et al.
Publicado: (2022)

Identification of a Twelve Epithelial-Mesenchymal Transition-Related lncRNA Prognostic Signature in Kidney Clear Cell Carcinoma
por: Xia, Qi-Dong, et al.
Publicado: (2022)

Analysis of epithelial–mesenchymal transition markers in psoriatic epidermal keratinocytes
por: Man, Xiao-Yong, et al.
Publicado: (2015)

Evaluation of Epithelial–Mesenchymal Transition Markers in Autoimmune Thyroid Diseases
por: Sacristán-Gómez, Pablo, et al.
Publicado: (2023)

Epithelial-mesenchymal transition-associated microRNA/mRNA signature is linked to metastasis and prognosis in clear-cell renal cell carcinoma
por: Mlcochova, Hana, et al.
Publicado: (2016)

MTDH promotes metastasis of clear cell renal cell carcinoma by activating SND1-mediated ERK signaling and epithelial-mesenchymal transition
por: He, Anbang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_r823h9a561lr2h085qs0693cca